A meta-analysis of two randomized studies evaluating patent foramen ovale (PFO) closure as a treatment strategy for migraine has shown significant benefits in several key endpoints, prompting the ...

Associated Stroke Causal Likelihood (PASCAL) classification has the ability to differentiate between patients with net ...

In patients with migraine who undergo transcatheter closure of patent foramen ovale (PFO), the presence of aura and of residual right-to-left shunt appear to influence the amount of migraine benefits, ...

Patent foramen ovale (PFO) may be associated with migraine, especially migraine with aura (MA), when the PFO is permanent right-left shunt (RLS), large RLS, and large-size PFO, a recent study found.

The first-ever guidelines for interventional cardiologists using percutaneous patent foramen ovale closure recommend expanding the use of the procedure beyond the Food and Drug Administration-approved ...

Please provide your email address to receive an email when new articles are posted on . High-risk patent foramen ovale was independently linked to a higher risk for decompression illness in scuba ...

ATLANTA -- Scenarios for patent foramen ovale (PFO) closure not covered by the pivotal trials were a key subject of guidelines released by the Society for Cardiovascular Angiography and Interventions ...

A “dose-response” relationship may exist between migraine and patent foramen ovale (PFO), according to a review published in Frontiers in Neurology. According to the American Heart Association, a PFO ...

Patent foramen ovale (PFO) closure in conjunction with optimal medical therapy can reduce both the number of migraine days and the frequency of attacks compared with medicine alone, according to a new ...

Please provide your email address to receive an email when new articles are posted on . NEW YORK — In certain cases, short-term tamponade with perfluoro-n-octane provides good anatomical and ...